Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
Active, not recruiting · NCT04009148 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome | BRCA-Mutated Ovarian Carcinoma; BRIP1 Gene Mutation; EPCAM; MLH1 Gene Mutation; MSH2 A636P; MSH6 Gene Mutation; PMS2 Gene Mutation; RAD51C Gene Mutation | Active, not recruiting | Not stated | 2026-05-14 | NCT04009148 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NYU Langone Health | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NYU Langone Health | New York | United States | 403 |